cancer research

Researchers report that epigenetic editing can silence hepatitis B virus, effectively banishing it rather than merely suppressing it. The approach targets the virus's gene activity without cutting DNA, offering a possible route toward a functional cure for a infection that affects hundreds of millions and is a leading cause of liver cancer. Readers are discussing the promise and hurdles before human use.

A 13-year-old child has reportedly been cured of DIPG, diffuse intrinsic pontine glioma, an aggressive brainstem cancer that has almost always been fatal in children. The case is being described as a world first, and it is drawing wide attention because DIPG has resisted decades of treatment efforts, with most children surviving less than a year after diagnosis. Families, researchers and clinicians are watching closely for confirmation and details of the treatment used.

Radiation oncology expert Eric Deutsch says science is expanding rapidly at the intersection of radiation therapy, immunology, and technology, as combined approaches such as radiotherapy paired with immunotherapy gain ground in cancer treatment. His remarks highlight how technological advances and immune-based research are reshaping how clinicians think about radiation's role beyond tumour destruction.

Dr Gevorg Tamamyan has been recognised as a candidate for WHO Director-General, drawing congratulations from AORTIC, the African Organisation for Research and Training in Cancer. The organisation praised his commitment to global health, equity and stronger health systems, highlighting his standing in the international oncology and global health community.